LivsMed Unveils a 90° Articulating Vessel Sealer

LivsMed has introduced to the world its ArtiSeal Vessel Sealing System, a tool for carrying out perpendicular seals on arteries and tissues. 

“ArtiSeal—the world’s first 90-degree double-jointed articulating vessel sealer—will give surgeons unprecedented access to targeted vessels and tissue bundles and the ability to achieve a true perpendicular seal,” LivsMed Founder/CEO Dr. Jung Joo Lee said.

Pre-existing studies show that perpendicular seals on tissue bundles may provide a higher burst pressure compared to angled seals created by existing straight vessel sealers. Indicated for minimally invasive or open general procedures, ArtiSeal can be used on arteries and tissue bundles up to and including those 7 mm in size.

“The launch of ArtiSeal is another example of LivsMed’s commitment on delivering disruptive technologies to a market that has lacked major laparoscopic surgical advances in recent years,” Dr. Lee stated.

As with all LivsMed instruments, ArtiSeal features 90-degree articulation of the instrument’s end effector, which moves in perfect synchronization with the surgeon’s natural wrist and hand movements as conveyed through the device’s ergonomic grip. This articulation, the instrument’s double-jointed jaw, locking mechanism, and RF energy combine, providing the desired perpendicular seal.

ArtiSeal’s advanced bipolar design is a proven safe and effective modality for sealing vessels and tissue bundles. The energy is delivered between the instrument’s jaws with minimal thermal spread on targeted tissue. This allows precise and safe sealing in difficult to reach tissue. The System includes a dedicated RF generator which is software upgradable, for ongoing, built-in safety features.

ArtiSeal is the latest addition to LivsMed’s product family, which includes the ArtiSential line of single-use laparoscopic instruments. ArtiSential offers the precision of robotic surgical platforms without the high cost. Its double-jointed end effectors allow various angles of approach with a full range of motion, even in difficult-to-reach spaces. Additionally, ArtiSential provides tactile feedback, allowing surgeons to apply the right pressure to delicate tissue.

Founded in South Korea, LivsMed strives to achieve a new paradigm of laparoscopic surgery where articulating technology is available to all surgeons. LivsMed’s ArtiSential line was introduced in Korea in 2018 and the United States in 2019. In the United States, ArtiSential received the Red Dot Design Award and recognition from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Working with physicians worldwide, LivsMed focuses on revolutionizing minimally invasive surgery, advancing patient outcomes, and extending patients’ lives.